Clinical Trial: Prostatic Artery Embolization Using Histoacryl as a Novel Embolizing Agent for Treatment of BPH

U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07904702) titled 'Prostatic Artery Embolization Using Histoacryl as a Novel Embolizing Agent for Treatment of BPH' on Oct. 23.

Brief Summary: Benign prostatic hyperplasia (BPH) is a common non-cancerous enlargement of the prostate gland in aging men that causes bothersome lower urinary tract symptoms (LUTS), including frequent urination, weak urinary stream, and difficulty emptying the bladder. Prostatic artery embolization (PAE) is a minimally invasive, image-guided catheter procedure that blocks blood flow to the prostate, leading to gland shrinkage and symptom relief. While traditional PAE utilizes particulate agents, N-butyl cyanoacrylate (NBCA /...